User contributions for Potionism
A user with 106 edits. Account created on 24 March 2010.
20 June 2012
- 01:2101:21, 20 June 2012 diff hist +4 Pegylated interferon No edit summary
- 01:2001:20, 20 June 2012 diff hist +288 Pegylated interferon No edit summary
- 01:1601:16, 20 June 2012 diff hist +153 User talk:Potionism →June 2012
- 00:3000:30, 20 June 2012 diff hist +2 Multiple sclerosis →Therapies
- 00:2900:29, 20 June 2012 diff hist −3 Pegylated interferon No edit summary
- 00:2800:28, 20 June 2012 diff hist +359 Pegylated interferon No edit summary
- 00:2400:24, 20 June 2012 diff hist 0 Multiple sclerosis →Therapies
- 00:2300:23, 20 June 2012 diff hist +333 Multiple sclerosis →Therapies
- 00:1500:15, 20 June 2012 diff hist +148 Migraine →Triptans
- 00:1200:12, 20 June 2012 diff hist +9 Migraine →Triptans
- 00:0200:02, 20 June 2012 diff hist +504 Migraine No edit summary
13 June 2012
- 03:1203:12, 13 June 2012 diff hist +518 Pharmacovigilance →International collaboration
- 03:0403:04, 13 June 2012 diff hist +348 Biopharmaceutical →Biosimilars
- 03:0003:00, 13 June 2012 diff hist +30 Biosimilar No edit summary
12 June 2012
- 01:1301:13, 12 June 2012 diff hist +318 Biosimilar →Approval processes
- 01:0601:06, 12 June 2012 diff hist +283 Melanoma No edit summary
- 01:0601:06, 12 June 2012 diff hist +364 Melanoma →Research
- 01:0001:00, 12 June 2012 diff hist −1 Drug development →Success rate
- 00:5900:59, 12 June 2012 diff hist +603 Drug development →Success rate
- 00:5600:56, 12 June 2012 diff hist +399 Drug development →Success rate
- 00:5300:53, 12 June 2012 diff hist +22 Stem cell →Toxicity Screening
- 00:5100:51, 12 June 2012 diff hist +9 Stem cell →Toxicity Screening
- 00:4700:47, 12 June 2012 diff hist +652 Stem cell No edit summary
- 00:4100:41, 12 June 2012 diff hist +4 Hepatotoxicity No edit summary
- 00:3800:38, 12 June 2012 diff hist +621 Hepatotoxicity No edit summary
19 October 2011
- 00:0300:03, 19 October 2011 diff hist +540 Patient-reported outcome No edit summary
18 October 2011
- 23:5023:50, 18 October 2011 diff hist +495 Quality of life (healthcare) →Why is it important?
- 23:3823:38, 18 October 2011 diff hist +590 New Drug Application →The actual application
- 23:3223:32, 18 October 2011 diff hist +691 Pharmaceutical industry →Product approval in the US
4 October 2011
- 23:0323:03, 4 October 2011 diff hist +503 Clinical trial →Participating in a clinical trial
- 23:0123:01, 4 October 2011 diff hist +503 Clinical trial →Locating trials
- 22:5622:56, 4 October 2011 diff hist +573 Clinical data management No edit summary
- 22:4722:47, 4 October 2011 diff hist +597 Lock (database) No edit summary
- 22:0422:04, 4 October 2011 diff hist −245 Drug repositioning No edit summary
- 21:5121:51, 4 October 2011 diff hist +469 Hepatitis C →Treatment
- 21:2521:25, 4 October 2011 diff hist +26 Viral vector →Gene therapy
- 21:2421:24, 4 October 2011 diff hist +26 Viral vector →Key properties of a viral vector
- 21:2221:22, 4 October 2011 diff hist +309 Viral vector No edit summary
- 21:1421:14, 4 October 2011 diff hist +45 Gene therapy No edit summary
- 21:0721:07, 4 October 2011 diff hist +289 Gene therapy →Non-viral methods
- 20:5920:59, 4 October 2011 diff hist +418 Gene delivery No edit summary
17 June 2011
- 05:4705:47, 17 June 2011 diff hist +493 Attention deficit hyperactivity disorder →Diet
- 05:3805:38, 17 June 2011 diff hist +4 B vitamins →Health benefits
- 05:3605:36, 17 June 2011 diff hist +39 B vitamins →Health benefits
- 05:3505:35, 17 June 2011 diff hist +450 B vitamins →Health benefits
- 05:2405:24, 17 June 2011 diff hist −4 Postmarketing surveillance No edit summary
- 05:2405:24, 17 June 2011 diff hist +60 Pharmacovigilance No edit summary
- 05:2305:23, 17 June 2011 diff hist +79 Postmarketing surveillance No edit summary
- 05:1005:10, 17 June 2011 diff hist 0 Postmarketing surveillance No edit summary
- 05:0905:09, 17 June 2011 diff hist +347 Postmarketing surveillance No edit summary
